Leicester Royal Infirmary — Leicester

Public research footprint of Leicester Royal Infirmary, compiled from the ClinicalTrials.gov public registry.

407

Registered studies

104

Active

Recruiting now

198

Completed

Stopped or withdrawn

Most-studied conditions

Ovarian Cancer · Breast Neoplasms · Metastatic Non-small Cell Lung Cancer With MTAP Deletion · Non Small Cell Lung Carcinoma

Recently updated registry entries

NCT06772623 — Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… (Recruiting)
NCT01804686 — A Long-term Extension Study of PCI-32765 (Ibrutinib) (Recruiting)
NCT05438043 — A Study of Daratumumab (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Leicester Royal Infirmary?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.